Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Latest 13D and 13G Filings > 13D Filing (0001123292-24-000023)

Filing Details

Accession Number:
0001123292-24-000023
Form Type:
13D Filing
Publication Date:
2024-02-06 19:00:00
Filed By:
Prime Movers Lab Fund I Lp
Company:
Heliogen Inc.
Filing Date:
2024-02-07
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Prime Movers Lab Fund I 0 0 0.0%
Prime Movers Lab GP I 0 0 0.0%
Heliogen PML SPV 0 0 0.0%
Prime Movers Lab Fund II 0 0 0.0%
Prime Movers Lab GP II 0 0 0.0%
Prime Movers Lab Fund III 0.0%
Prime Movers Lab GP III 0.0%
Prime Movers Lab 0.0%
Dakin Sloss 0.0%
Filing


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


SCHEDULE 13D
(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
§ 240.13d-2(a)
(Amendment No. 4)*


Heliogen, Inc.
(Name of Issuer)
 

Common Stock, par value $0.0001 per share
(Title of Class of Securities)
 

 
42329E105
(CUSIP Number)


TAYLOR FRANKEL
c/o PRIME MOVERS LAB
P.O. Box 12829
Jackson, Wyoming 83002
(307) 203-5036
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)


September 5, 2023
(Date of Event Which Requires Filing of this Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☒.

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP NO.
42329E105

 
 

 
1
 
NAME OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
Prime Movers Lab Fund I LP
 
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☒
 
 
 
 
(b) ☐
 
 
 
 
 
 
 
3
 
SEC USE ONLY
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
4
 
SOURCE OF FUNDS
 
 
 
 
 
 
 
 
 
 
WC
 
 
5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
☐
 
 
 
  
 
 
 
 
 
 
 
 
6
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
 
 
 
 
 
 
 
 
Delaware
 
NUMBER OF
 
7
 
SOLE VOTING POWER
 
SHARES
 
 
 
 
 
BENEFICIALLY
 
 
 
 
- 0 -
 
OWNED BY
 
8
 
SHARED VOTING POWER
 
EACH
 
 
 
 
 
REPORTING
 
 
 
 
-0-
 
PERSON WITH
 
9
 
SOLE DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
 
10
 
SHARED DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
 -0-
 
 
11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
-0-
 
 
12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
☐
 
 
 
  
 
 
 
 
 
 
 
 
13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
 
 
 
 
 
 
 
 
0.0% (1)
 
 
14
 
TYPE OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
PN
 

1 The percentages used herein and in the rest of this Schedule 13D calculated based on 5,908,645 shares of common stock outstanding as of November 9, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 14, 2023. The beneficial ownership information reported herein and the transaction information reported in Item 5 below reflects a 1-for-35 reverse stock split  of the Issuer’s Common Stock effected by the Issuer on  August 31, 2023.


CUSIP NO.
42329E105

 
 

 
1
 
NAME OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
Prime Movers Lab GP I LLC
 
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☒
 
 
 
 
(b) ☐
 
 
 
 
 
 
 
3
 
SEC USE ONLY
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
4
 
SOURCE OF FUNDS
 
 
 
 
 
 
 
 
 
 
AF
 
 
5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
☐
 
 
 
  
 
 
 
 
 
 
 
 
6
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
 
 
 
 
 
 
 
 
Delaware
 
NUMBER OF
 
7
 
SOLE VOTING POWER
 
SHARES
 
 
 
 
 
BENEFICIALLY
 
 
 
 
- 0 -
 
OWNED BY
 
8
 
SHARED VOTING POWER
 
EACH
 
 
 
 
 
REPORTING
 
 
 
 
-0-
 
PERSON WITH
 
9
 
SOLE DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
 
10
 
SHARED DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
-0-
 
 
11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
-0-
 
 
12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
☐
 
 
 
  
 
 
 
 
 
 
 
 
13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
 
 
 
 
 
 
 
 
0.0%
 
 
14
 
TYPE OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
OO
 


CUSIP NO.
42329E105

 
 

 
1
 
NAME OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
Heliogen PML SPV 1 LP
 
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☒
 
 
 
 
(b) ☐
 
 
 
 
 
 
 
3
 
SEC USE ONLY
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
4
 
SOURCE OF FUNDS
 
 
 
 
 
 
 
 
 
 
WC
 
 
5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
☐
 
 
 
  
 
 
 
 
 
 
 
 
6
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
 
 
 
 
 
 
 
 
Delaware
 
NUMBER OF
 
7
 
SOLE VOTING POWER
 
SHARES
 
 
 
 
 
BENEFICIALLY
 
 
 
 
- 0 -
 
OWNED BY
 
8
 
SHARED VOTING POWER
 
EACH
 
 
 
 
 
REPORTING
 
 
 
 
-0-
 
PERSON WITH
 
9
 
SOLE DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
 
10
 
SHARED DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
-0-
 
 
11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
-0-
 
 
12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
☐
 
 
 
  
 
 
 
 
 
 
 
 
13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
 
 
 
 
 
 
 
 
0.0%
 
 
14
 
TYPE OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
PN
 


CUSIP NO.
42329E105

 
 

 
1
 
NAME OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
Prime Movers Lab Fund II LP
 
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☒
 
 
 
 
(b) ☐
 
 
 
 
 
 
 
3
 
SEC USE ONLY
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
4
 
SOURCE OF FUNDS
 
 
 
 
 
 
 
 
 
 
WC
 
 
5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
☐
 
 
 
  
 
 
 
 
 
 
 
 
6
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
 
 
 
 
 
 
 
 
Delaware
 
NUMBER OF
 
7
 
SOLE VOTING POWER
 
SHARES
 
 
 
 
 
BENEFICIALLY
 
 
 
 
- 0 -
 
OWNED BY
 
8
 
SHARED VOTING POWER
 
EACH
 
 
 
 
 
REPORTING
 
 
 
 
- 0 -
 
PERSON WITH
 
9
 
SOLE DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
 
10
 
SHARED DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
☐
 
 
 
  
 
 
 
 
 
 
 
 
13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
 
 
 
 
 
 
 
 
0.0%
 
 
14
 
TYPE OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
PN
 


CUSIP NO.
42329E105

 
 

 
1
 
NAME OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
Prime Movers Lab GP II LLC
 
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☒
 
 
 
 
(b) ☐
 
 
 
 
 
 
 
3
 
SEC USE ONLY
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
4
 
SOURCE OF FUNDS
 
 
 
 
 
 
 
 
 
 
AF
 
 
5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
☐
 
 
 
  
 
 
 
 
 
 
 
 
6
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
 
 
 
 
 
 
 
 
Delaware
 
NUMBER OF
 
7
 
SOLE VOTING POWER
 
SHARES
 
 
 
 
 
BENEFICIALLY
 
 
 
 
- 0 -
 
OWNED BY
 
8
 
SHARED VOTING POWER
 
EACH
 
 
 
 
 
REPORTING
 
 
 
 
-0-
 
PERSON WITH
 
9
 
SOLE DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
 
10
 
SHARED DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
-0-
 
 
11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
-0-
 
 
12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
☐
 
 
 
  
 
 
 
 
 
 
 
 
13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
 
 
 
 
 
 
 
 
0.0%
 
 
14
 
TYPE OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
OO
 


CUSIP NO.
42329E105

 
 

 
1
 
NAME OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
Prime Movers Lab Fund III LP
 
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☒
 
 
 
 
(b) ☐
 
 
 
 
 
 
 
3
 
SEC USE ONLY
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
4
 
SOURCE OF FUNDS
 
 
 
 
 
 
 
 
 
 
AF
 
 
5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
☐
 
 
 
  
 
 
 
 
 
 
 
 
6
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
 
 
 
 
 
 
 
 
Delaware
 
NUMBER OF
 
7
 
SOLE VOTING POWER
 
SHARES
 
 
 
 
 
BENEFICIALLY
 
 
 
 
- 0 -
 
OWNED BY
 
8
 
SHARED VOTING POWER
 
EACH
 
 
 
 
 
REPORTING
 
 
 
 
- 0 -
 
PERSON WITH
 
9
 
SOLE DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
 
10
 
SHARED DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
☐
 
 
 
  
 
 
 
 
 
 
 
 
13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
 
 
 
 
 
 
 
 
0.0%
 
 
14
 
TYPE OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
PN
 


CUSIP NO.
42329E105

 
 

 
1
 
NAME OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
Prime Movers Lab GP III LLC
 
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☒
 
 
 
 
(b) ☐
 
 
 
 
 
 
 
3
 
SEC USE ONLY
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
4
 
SOURCE OF FUNDS
 
 
 
 
 
 
 
 
 
 
AF
 
 
5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
☐
 
 
 
  
 
 
 
 
 
 
 
 
6
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
 
 
 
 
 
 
 
 
Delaware
 
NUMBER OF
 
7
 
SOLE VOTING POWER
 
SHARES
 
 
 
 
 
BENEFICIALLY
 
 
 
 
- 0 -
 
OWNED BY
 
8
 
SHARED VOTING POWER
 
EACH
 
 
 
 
 
REPORTING
 
 
 
 
- 0 -
 
PERSON WITH
 
9
 
SOLE DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
 
10
 
SHARED DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
☐
 
 
 
  
 
 
 
 
 
 
 
 
13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
 
 
 
 
 
 
 
 
0.0%
 
 
14
 
TYPE OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
OO
 


CUSIP NO.
42329E105

 
 

 
1
 
NAME OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
Prime Movers Lab LLC
 
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☒
 
 
 
 
(b) ☐
 
 
 
 
 
 
 
3
 
SEC USE ONLY
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
4
 
SOURCE OF FUNDS
 
 
 
 
 
 
 
 
 
 
AF
 
 
5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
☐
 
 
 
  
 
 
 
 
 
 
 
 
6
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
 
 
 
 
 
 
 
 
Delaware
 
NUMBER OF
 
7
 
SOLE VOTING POWER
 
SHARES
 
 
 
 
 
BENEFICIALLY
 
 
 
 
- 0 -
 
OWNED BY
 
8
 
SHARED VOTING POWER
 
EACH
 
 
 
 
 
REPORTING
 
 
 
 
- 0 -
 
PERSON WITH
 
9
 
SOLE DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
 
10
 
SHARED DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
☐
 
 
 
  
 
 
 
 
 
 
 
 
13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
 
 
 
 
 
 
 
 
0.0%
 
 
14
 
TYPE OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
OO
 


CUSIP NO.
42329E105

 
 

 
1
 
NAME OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
Dakin Sloss
 
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☒
 
 
 
 
(b) ☐
 
 
 
 
 
 
 
3
 
SEC USE ONLY
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
4
 
SOURCE OF FUNDS
 
 
 
 
 
 
 
 
 
 
AF
 
 
5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
☐
 
 
 
  
 
 
 
 
 
 
 
 
6
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
 
 
 
 
 
 
 
 
United States
 
NUMBER OF
 
7
 
SOLE VOTING POWER
 
SHARES
 
 
 
 
 
BENEFICIALLY
 
 
 
 
- 0 -
 
OWNED BY
 
8
 
SHARED VOTING POWER
 
EACH
 
 
 
 
 
REPORTING
 
 
 
 
-0-
 
PERSON WITH
 
9
 
SOLE DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
- 0 -
 
 
 
10
 
SHARED DISPOSITIVE POWER
 
 
 
 
 
 
 
 
 
 
 
 
-0-
 
 
11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
-0-
 
 
12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
☐
 
 
 
  
 
 
 
 
 
 
 
 
13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
 
 
 
 
 
 
 
 
0.0%
 
 
14
 
TYPE OF REPORTING PERSON
 
 
 
 
 
 
 
 
 
 
IN
 

EXPLANATORY NOTE
This Amendment No.4 (this “Amendment No. 4”) to the Statement on Schedule 13D (as amended, the “Statement”) is being filed with the Securities and Exchange Commission (the “Commission”) relating to the common stock, par value $0.0001 per share (the “Common Stock”) of Heliogen, Inc., a corporation organized under the laws of the state of Delaware (the “Issuer”). The beneficial ownership information reported herein and the transaction information reported in Item 5 below reflects a 1-for-35 reverse stock split  of the Issuer’s Common Stock effected by the Issuer on  August 31, 2023. This Amendment amends and supplements the Statement originally filed on February 13, 2023 with the Commission. Unless otherwise defined herein, capitalized terms used herein shall have the meanings ascribed thereto in the Statement. Except as otherwise provided herein, each Item of the Schedule 13D remains unchanged.
 
Item 5.
Interest in Securities of the Issuer.
                       
(a) — (b) 
See Rows 7-11 and Row 13 of each cover page.
 
(c)
The Reporting Person has effected the following transactions since July 6, 2023:
 
(i) On August 24, 2023 each of the following Reporting Persons distributed the following amounts of shares of Common Stock to such Reporting Person’s limited partners in connection with a pro-rata distribution plan (1) Prime Movers Lab Fund I LP distributed 87,296 shares of Common Stock and (2) Heliogen PML SPV 1 LP distributed 55,561 shares of Common Stock;
 
(ii) On September 5, 2023 each of the following Reporting Persons sold the following amounts of shares of Common Stock for an average weighted price of $8.4532 (1) Prime Movers Lab Fund I LP sold 19,515 shares of Common Stock and (2) Heliogen PML SPV 1 LP sold 12,420 shares of Common Stock;
 
(iii) On September 6, 2023 each of the following Reporting Persons sold the following amounts of shares of Common Stock for an average weighted price of $7.4767 (1) Prime Movers Lab Fund I LP sold 4,889 shares of Common Stock and (2) Heliogen PML SPV 1 LP sold 3,111 shares of Common Stock;
 
(iv) On September 7, 2023 each of the following Reporting Persons sold the following amounts of shares of Common Stock for an average weighted price of $5.5319 (1) Prime Movers Lab Fund I LP sold 15,384 shares of Common Stock and (2) Heliogen PML SPV 1 LP sold 9,792 shares of Common Stock;
 
(v) On September 14, 2023 each of the following Reporting Persons sold the following amounts of shares of Common Stock for an average weighted price of $4.4912 (1) Prime Movers Lab Fund I LP sold 8,327 shares of Common Stock and (2) Heliogen PML SPV 1 LP sold 5,300 shares of Common Stock;

(vi) On September 15, 2023 each of the following Reporting Persons sold the following amounts of shares of Common Stock for an average weighted price of $4.0871 (1) Prime Movers Lab Fund I LP sold 3,179 shares of Common Stock and (2) Heliogen PML SPV 1 LP sold 2,024 shares of Common Stock; and

(vii) On September 19, 2023 each of the following Reporting Persons distributed the following amounts of shares of Common Stock to such Reporting Person’s limited partners in connection with a pro-rata distribution plan (1) Prime Movers Lab Fund I LP distributed 160,761 shares of Common Stock and (2) Heliogen PML SPV 1 LP distributed 102,319 shares of Common Stock.
             

(d)
Not applicable.

(e)
This statement is being filed to report the fact that as of September 5, 2023, each of the Reporting Persons ceased to be the beneficial owner of more than five percent of the class of securities.
 


SIGNATURE

   After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.
 
Dated: February 7, 2024


PRIME MOVERS LAB FUND I LP
 
 
 
 

By:
Prime Movers Lab GP I LLC
 

Its:
General Partner
 

 
 
 

By:
/s/ Taylor Frankel
 

Name:
Taylor Frankel
 

Title:
Authorized Person
 


PRIME MOVERS LAB GP I LLC
 
 
 
 
 
By:
Prime Movers Lab LLC
 

Its:
Managing Member
 

 
 
 

By:
/s/ Taylor Frankel
 

Name:
Taylor Frankel
 

Title:
Authorized Person
 


HELIOGEN PML SPV 1 LP
 
 
 
 
 
By:
Prime Movers Lab GP II LLC
 

Its:
General Partner
 

 
 
 

By:
/s/ Taylor Frankel
 

Name:
Taylor Frankel
 

Title:
Authorized Person
 


PRIME MOVERS LAB GP II LLC
 
 
 
 

By:
Prime Movers Lab LLC
 

Its:
Managing Member
 

 
 
 

By:
/s/ Taylor Frankel
 

Name:
Taylor Frankel
 

Title:
Authorized Person
 


PRIME MOVERS LAB FUND II LP
 
 
 
 
 
By:
Prime Movers Lab GP II LLC
 

Its:
General Partner
 

 
 
 

By:
/s/ Taylor Frankel
 

Name:
Taylor Frankel
 

Title:
Authorized Person
 


PRIME MOVERS LAB FUND III LP
 
 
 
 
 
By:
Prime Movers Lab GP III LLC
 

Its:
General Partner
 

 
 
 

By:
/s/ Taylor Frankel
 

Name:
Taylor Frankel
 

Title:
Authorized Person
 



PRIME MOVERS LAB GP III LLC
 
 
 
 
 
By:
Prime Movers Lab LLC
 

Its:
Managing Member
 

 
 
 

By:
/s/ Taylor Frankel
 

Name:
Taylor Frankel
 

Title:
Authorized Person
 


PRIME MOVERS LAB  LLC
 
 
 
 
 
By:
/s/ Taylor Frankel
 

Name:
Taylor Frankel
 

Title:
Authorized Person
 



/s/ Dakin Sloss
 


Dakin Sloss